Cyclofoetoside B
Internal ID | f9c4c5fe-613d-488f-86f9-5b06d5f1bb9c |
Taxonomy | Lipids and lipid-like molecules > Steroids and steroid derivatives > Steroidal glycosides > Steroidal saponins > Cucurbitacin glycosides |
IUPAC Name | (2R,3R,4R,5R,6S)-2-[[(2R,3S,4S,5R,6R)-6-[[(1S,3R,6S,7S,8R,11S,12S,14S,16R)-15-[(2R,5S)-5,6-dihydroxy-6-methylheptan-2-yl]-7-(hydroxymethyl)-7,12,16-trimethyl-6-[(2S,3R,4S,5S)-3,4,5-trihydroxyoxan-2-yl]oxy-14-pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl]oxy]-3,4,5-trihydroxyoxan-2-yl]methoxy]-6-methyloxane-3,4,5-triol |
SMILES (Canonical) | CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3CC4(C5CCC6C(C(CCC67C5(C7)CCC4(C3C(C)CCC(C(C)(C)O)O)C)OC8C(C(C(CO8)O)O)O)(C)CO)C)O)O)O)O)O)O |
SMILES (Isomeric) | C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)O[C@H]3C[C@]4([C@@H]5CC[C@H]6[C@@]([C@H](CC[C@]67[C@]5(C7)CC[C@@]4(C3[C@H](C)CC[C@@H](C(C)(C)O)O)C)O[C@H]8[C@@H]([C@H]([C@H](CO8)O)O)O)(C)CO)C)O)O)O)O)O)O |
InChI | InChI=1S/C47H80O18/c1-21(8-11-28(50)42(3,4)59)30-24(63-41-38(58)35(55)33(53)25(64-41)18-61-39-37(57)34(54)31(51)22(2)62-39)16-45(7)27-10-9-26-43(5,20-48)29(65-40-36(56)32(52)23(49)17-60-40)12-13-46(26)19-47(27,46)15-14-44(30,45)6/h21-41,48-59H,8-20H2,1-7H3/t21-,22+,23+,24+,25-,26+,27+,28+,29+,30?,31+,32+,33-,34-,35+,36-,37-,38-,39-,40+,41-,43-,44-,45+,46-,47+/m1/s1 |
InChI Key | JDYWIMCSAUNOHC-OOLFRTMQSA-N |
Popularity | 1 reference in papers |
Molecular Formula | C47H80O18 |
Molecular Weight | 933.10 g/mol |
Exact Mass | 932.53446570 g/mol |
Topological Polar Surface Area (TPSA) | 298.00 Ų |
XlogP | 0.00 |
Atomic LogP (AlogP) | -0.58 |
H-Bond Acceptor | 18 |
H-Bond Donor | 12 |
Rotatable Bonds | 13 |
108333-83-1 |
(2R,3R,4R,5R,6S)-2-[[(2R,3S,4S,5R,6R)-6-[[(1S,3R,6S,7S,8R,11S,12S,14S,16R)-15-[(2R,5S)-5,6-dihydroxy-6-methylheptan-2-yl]-7-(hydroxymethyl)-7,12,16-trimethyl-6-[(2S,3R,4S,5S)-3,4,5-trihydroxyoxan-2-yl]oxy-14-pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl]oxy]-3,4,5-trihydroxyoxan-2-yl]methoxy]-6-methyloxane-3,4,5-triol |
C08939 |
CHEBI:4002 |
DTXSID40331668 |
Q27106285 |

Target | Value | Probability (raw) | Probability (%) |
---|---|---|---|
Human Intestinal Absorption | - | 0.4805 | 48.05% |
Caco-2 | - | 0.8853 | 88.53% |
Blood Brain Barrier | - | 0.5750 | 57.50% |
Human oral bioavailability | - | 0.7286 | 72.86% |
Subcellular localzation | Mitochondria | 0.5846 | 58.46% |
OATP2B1 inhibitior | - | 1.0000 | 100.00% |
OATP1B1 inhibitior | + | 0.8580 | 85.80% |
OATP1B3 inhibitior | + | 0.9122 | 91.22% |
MATE1 inhibitior | - | 0.9800 | 98.00% |
OCT2 inhibitior | - | 0.5750 | 57.50% |
BSEP inhibitior | - | 0.5853 | 58.53% |
P-glycoprotein inhibitior | + | 0.7521 | 75.21% |
P-glycoprotein substrate | + | 0.6662 | 66.62% |
CYP3A4 substrate | + | 0.7312 | 73.12% |
CYP2C9 substrate | - | 0.8018 | 80.18% |
CYP2D6 substrate | - | 0.8301 | 83.01% |
CYP3A4 inhibition | - | 0.9472 | 94.72% |
CYP2C9 inhibition | - | 0.7996 | 79.96% |
CYP2C19 inhibition | - | 0.8391 | 83.91% |
CYP2D6 inhibition | - | 0.9505 | 95.05% |
CYP1A2 inhibition | - | 0.8918 | 89.18% |
CYP2C8 inhibition | + | 0.6977 | 69.77% |
CYP inhibitory promiscuity | - | 0.9671 | 96.71% |
UGT catelyzed | + | 0.9000 | 90.00% |
Carcinogenicity (binary) | - | 0.9700 | 97.00% |
Carcinogenicity (trinary) | Non-required | 0.6868 | 68.68% |
Eye corrosion | - | 0.9895 | 98.95% |
Eye irritation | - | 0.9060 | 90.60% |
Skin irritation | - | 0.7152 | 71.52% |
Skin corrosion | - | 0.9483 | 94.83% |
Ames mutagenesis | - | 0.5932 | 59.32% |
Human Ether-a-go-go-Related Gene inhibition | + | 0.7855 | 78.55% |
Micronuclear | - | 0.8000 | 80.00% |
Hepatotoxicity | - | 0.6747 | 67.47% |
skin sensitisation | - | 0.9113 | 91.13% |
Respiratory toxicity | - | 0.5889 | 58.89% |
Reproductive toxicity | + | 0.7444 | 74.44% |
Mitochondrial toxicity | - | 0.5875 | 58.75% |
Nephrotoxicity | - | 0.9310 | 93.10% |
Acute Oral Toxicity (c) | I | 0.6066 | 60.66% |
Estrogen receptor binding | + | 0.7252 | 72.52% |
Androgen receptor binding | + | 0.7454 | 74.54% |
Thyroid receptor binding | - | 0.5698 | 56.98% |
Glucocorticoid receptor binding | + | 0.6579 | 65.79% |
Aromatase binding | + | 0.6491 | 64.91% |
PPAR gamma | + | 0.7524 | 75.24% |
Honey bee toxicity | - | 0.6455 | 64.55% |
Biodegradation | - | 0.7750 | 77.50% |
Crustacea aquatic toxicity | - | 0.7100 | 71.00% |
Fish aquatic toxicity | + | 0.8024 | 80.24% |
Proven Targets:
CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
---|---|---|---|---|---|
No proven targets yet! |
Predicted Targets (via Super-PRED):
CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
---|---|---|---|---|
CHEMBL253 | P34972 | Cannabinoid CB2 receptor | 99.60% | 97.25% |
CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 99.26% | 91.11% |
CHEMBL218 | P21554 | Cannabinoid CB1 receptor | 97.42% | 96.61% |
CHEMBL3137262 | O60341 | LSD1/CoREST complex | 94.94% | 97.09% |
CHEMBL2581 | P07339 | Cathepsin D | 94.87% | 98.95% |
CHEMBL5888 | Q99558 | Mitogen-activated protein kinase kinase kinase 14 | 93.81% | 100.00% |
CHEMBL1937 | Q92769 | Histone deacetylase 2 | 93.78% | 94.75% |
CHEMBL1907605 | P24864 | Cyclin-dependent kinase 2/cyclin E1 | 92.98% | 92.88% |
CHEMBL284 | P27487 | Dipeptidyl peptidase IV | 92.22% | 95.69% |
CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 92.20% | 96.09% |
CHEMBL1806 | P11388 | DNA topoisomerase II alpha | 91.69% | 89.00% |
CHEMBL6136 | O60341 | Lysine-specific histone demethylase 1 | 91.19% | 95.58% |
CHEMBL226 | P30542 | Adenosine A1 receptor | 91.01% | 95.93% |
CHEMBL344 | Q99705 | Melanin-concentrating hormone receptor 1 | 90.69% | 92.50% |
CHEMBL4303 | P08238 | Heat shock protein HSP 90-beta | 89.94% | 96.77% |
CHEMBL2842 | P42345 | Serine/threonine-protein kinase mTOR | 88.04% | 92.78% |
CHEMBL2007625 | O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | 87.88% | 99.00% |
CHEMBL1163125 | O60885 | Bromodomain-containing protein 4 | 87.33% | 97.31% |
CHEMBL4302 | P08183 | P-glycoprotein 1 | 87.32% | 92.98% |
CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 87.12% | 95.89% |
CHEMBL3714130 | P46095 | G-protein coupled receptor 6 | 86.93% | 97.36% |
CHEMBL2274 | Q9H228 | Sphingosine 1-phosphate receptor Edg-8 | 86.83% | 100.00% |
CHEMBL204 | P00734 | Thrombin | 86.55% | 96.01% |
CHEMBL4105786 | P41182 | B-cell lymphoma 6 protein | 86.37% | 92.86% |
CHEMBL1293249 | Q13887 | Kruppel-like factor 5 | 86.34% | 86.33% |
CHEMBL1951 | P21397 | Monoamine oxidase A | 86.12% | 91.49% |
CHEMBL1741186 | P51449 | Nuclear receptor ROR-gamma | 85.80% | 99.17% |
CHEMBL241 | Q14432 | Phosphodiesterase 3A | 85.57% | 92.94% |
CHEMBL2955 | O95136 | Sphingosine 1-phosphate receptor Edg-5 | 85.05% | 92.86% |
CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 84.95% | 94.45% |
CHEMBL4482 | O96013 | Serine/threonine-protein kinase PAK 4 | 84.60% | 95.42% |
CHEMBL1994 | P08235 | Mineralocorticoid receptor | 84.44% | 100.00% |
CHEMBL1293316 | Q9HBX9 | Relaxin receptor 1 | 84.21% | 82.50% |
CHEMBL4005 | P42336 | PI3-kinase p110-alpha subunit | 84.19% | 97.47% |
CHEMBL203 | P00533 | Epidermal growth factor receptor erbB1 | 83.86% | 97.34% |
CHEMBL259 | P32245 | Melanocortin receptor 4 | 83.86% | 95.38% |
CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 83.80% | 97.14% |
CHEMBL3476 | O15111 | Inhibitor of nuclear factor kappa B kinase alpha subunit | 83.68% | 95.83% |
CHEMBL2373 | P21730 | C5a anaphylatoxin chemotactic receptor | 83.45% | 92.62% |
CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 83.45% | 96.90% |
CHEMBL3892 | Q99500 | Sphingosine 1-phosphate receptor Edg-3 | 83.22% | 97.29% |
CHEMBL2959 | Q08881 | Tyrosine-protein kinase ITK/TSK | 83.08% | 95.00% |
CHEMBL3145 | P42338 | PI3-kinase p110-beta subunit | 83.06% | 98.75% |
CHEMBL4187 | Q99250 | Sodium channel protein type II alpha subunit | 82.55% | 95.50% |
CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 82.35% | 96.47% |
CHEMBL1977 | P11473 | Vitamin D receptor | 82.02% | 99.43% |
CHEMBL225 | P28335 | Serotonin 2c (5-HT2c) receptor | 81.62% | 89.62% |
CHEMBL206 | P03372 | Estrogen receptor alpha | 81.60% | 97.64% |
CHEMBL5747 | Q92793 | CREB-binding protein | 81.21% | 95.12% |
CHEMBL1871 | P10275 | Androgen Receptor | 80.81% | 96.43% |
CHEMBL4016 | P42262 | Glutamate receptor ionotropic, AMPA 2 | 80.61% | 86.92% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
Thalictrum foetidum |
PubChem | 441917 |
LOTUS | LTS0105465 |
wikiData | Q27106285 |